Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00260871|
Recruitment Status : Unknown
Verified July 2011 by National Health Research Institutes, Taiwan.
Recruitment status was: Active, not recruiting
First Posted : December 2, 2005
Last Update Posted : July 29, 2011
|Condition or disease|
This research proposal intends to integrate epidemiologists, biostatisticians, clinicians, molecular biologists/geneticists to identify susceptible genes for lung cancer, especially for female lung adenocarcinoma, and to study the relationship between gene polymorphisms and clinical outcomes of lung cancer patients. Our objective is to find gene markers for developing useful screening tools for the high risk group in order to prevent or early detect lung cancer, especially female lung adenocarcinoma.
The specific aims of this subproject include:
- Establish and maintain the research network that will recruit and follow up the subjects and families for the GEFLAC study; keeping control of the progress of the study.
- Coordinate all the subprojects such as integrating genotyping data with clinical data and environment data.
- Continue to employ the candidate gene approach to examine the contribution of specific genes to the lung cancer.
- Generate genotyping data for candidate genes in the exploring stage and prioritize SNPs of candidate genes for large scale studies.
- Identify susceptible genes/candidate genes to develop multiplex PCR for screening.
|Study Type :||Observational|
|Estimated Enrollment :||1500 participants|
|Observational Model:||Case Control|
|Official Title:||Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications-focusing on Female Lung Adenocarcinoma (GEFLAC)|
|Study Start Date :||May 2002|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00260871
|Division of Biostatistics and Bioinformatics, NHRI|
|Miaoli county, Taiwan, 350|
|Study Director:||Chao Hsiung, PhD||NHRI|